StockData
Palvella Therapeutics, Inc. logo

Palvella Therapeutics, Inc. (PVLA) stock

PVLANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$146.58+2.23 (+1.54%)

Close on Nov 18, 2026Market cap $2.11BP/E –Yield –

Palvella Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Palvella Therapeutics's price to book ratio was 10.9× on Nov 11, 2026, against 29.5× a year earlier. Over the last 5 years it ranged from 0.5× to 59.7×, with a median of 4.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202610.9×−19.1
2025Dec 31, 202530.0×+29.5
2024Jan 31, 20240.5×+0.0
2023Dec 29, 20230.5×−1.7
2022Dec 30, 20222.2×−2.9
2021Dec 31, 20215.0×+1.8
2020Dec 31, 20203.2×−5.5
2019Dec 31, 20198.7×+5.8
2018Dec 31, 20182.9×−71.2
2017Dec 29, 201774.0×+72.1
2016Dec 30, 20161.9×−0.8
2015Dec 31, 20152.7×–

More Palvella Therapeutics figures

See a number that looks wrong?